GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,070,000 | -14.6% | 39,349 | -14.0% | 1.46% | -14.4% |
| Q1 2019 | $2,423,000 | -5.8% | 45,771 | -26.9% | 1.70% | -15.9% |
| Q4 2018 | $2,571,000 | +25.4% | 62,643 | +16.1% | 2.03% | +51.0% |
| Q3 2018 | $2,050,000 | -16.5% | 53,951 | -0.7% | 1.34% | -17.6% |
| Q2 2018 | $2,455,000 | +22.1% | 54,317 | +30.5% | 1.63% | +13.5% |
| Q1 2018 | $2,010,000 | +12.4% | 41,610 | -8.4% | 1.44% | -6.5% |
| Q4 2017 | $1,788,000 | +2.5% | 45,441 | -19.1% | 1.53% | +11.2% |
| Q3 2017 | $1,744,000 | +20.9% | 56,157 | +6.5% | 1.38% | +8.3% |
| Q2 2017 | $1,442,000 | – | 52,709 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |